Repair Biotechnologies’ REP-0004 mRNA therapy gains FDA orphan drug designation and demonstrates rapid plaque regression in mouse models, potentially revolutionizing cardiovascular care. An mRNA...
Aged gut microbes release harmful extracellular vesicles that damage tissues, offering new therapeutic targets beyond fecal transplants. A groundbreaking study shows that aged gut bacteria secrete ves...
The 2026 Alzheimer’s clinical trials pipeline shows a strategic shift from amyloid to inflammation and tau targets, with combination therapies and repurposed drugs leading the way. In 2026, the Alzh...
A March 2025 study in Cell Reports Medicine finds that muscle loss from GLP-1 drugs mirrors ordinary weight loss, alleviating public concern. A new study reassures that GLP-1 drugs do not cause dispro...
New research reveals that pulsed electromagnetic fields can activate gene therapy in aged mice, improving survival and reducing aging markers, but ethical questions loom. A groundbreaking study demons...
A new study in Aging Cell uncovers a bidirectional feedback loop between intestinal aging and gut microbiome changes, accelerating systemic inflammation. A study in Aging Cell reveals how age-related ...
A 2025 study on Tibetan herders shows 30% higher inflammatory markers, contrasting with moderate altitude benefits. Implications for aging research and hypoxia-based therapies. High altitude may accel...
A 2024 JAMA Network Open study finds that napping over 30 minutes daily may raise mortality risk in older adults, but experts urge caution in interpreting the findings. A new study links excessive nap...
A January 2025 Cell Metabolism study reveals obesity induces lasting epigenetic changes in T cells, causing persistent inflammation even after weight loss, challenging current recovery assumptions. Ne...
A new study reveals that dasatinib and quercetin (D+Q) cause demyelination in mice, raising safety concerns as over 30 clinical trials test the combo for age-related diseases. A study in Nature Aging ...
